EXOSC9

EXOSC9 (PM/Scl-75) is a structural subunit of the multi-subunit RNA exosome that drives post-transcriptional RNA processing and degradation across multiple developmental and cellular contexts (PMID:12788944, PMID:29727687). Its N-terminally extended form, bearing 84 additional residues, is required for incorporation into the exosome through direct protein-protein contacts with the hRrp46p and hRrp41p subunits, whereas a shorter isoform cannot associate (PMID:12788944). A C-terminal basic region carries a nuclear localization signal that specifically directs the assembled exosome to the nucleolus without being required for complex association (PMID:12788944). EXOSC9 is required for whole-complex exosome assembly: recessive disease variants reduce EXOSC9 protein and disrupt assembly of the entire exosome, causing loss of cerebellum/hindbrain tissue and failure of motor neuron development and migration in zebrafish, defining EXOSC9 as a cause of pontocerebellar hypoplasia with spinal motor neuronopathy (PMID:29727687). Beyond core assembly, EXOSC9 supports epidermal integrity and ciliated-cell formation in Xenopus skin (PMID:26546114), promotes P-body formation and stress resistance through its RNA-binding motif (PMID:32518284), and is recruited to telomeres by SUMO-modified HP1α to degrade the lncRNA TERRA in a cell-cycle-dependent manner, limiting telomeric R-loops and DNA damage (PMID:37887339). During apoptosis EXOSC9 is cleaved at Asp369 most efficiently by caspase-1, with the N-terminal fragment retaining partial exosome association (PMID:17280603).

1. 2003 High

   It was unknown how PM/Scl-75 joins the exosome and what governs its localization; mapping the assembly interface and a targeting signal established the protein as a structural exosome subunit with a dedicated nucleolar-targeting element.

   Evidence Co-IP, mammalian two-hybrid, deletion mutagenesis, and fluorescence localization in mammalian cells

   PMID:12788944

   Open questions at the time

   • Atomic structure of the EXOSC9-hRrp46p/hRrp41p interface not resolved
   • Mechanism by which the NLS recruits nuclear import machinery not defined
2. 2007 High

   Whether EXOSC9 is a target of programmed cell death machinery was unknown; identifying caspase-1 cleavage at Asp369 linked the exosome subunit to apoptotic processing.

   Evidence In vitro cleavage with recombinant caspases, inhibitor panel, site mapping, and Co-IP of fragments

   PMID:17280603

   Open questions at the time

   • Functional consequence of cleavage for exosome activity in apoptotic cells not established
   • Whether cleavage occurs in physiological apoptosis in vivo untested
3. 2015 Medium

   The developmental requirement for the RNA exosome in epithelial tissue was unclear; loss of exosc9 in Xenopus revealed a post-transcriptional role in skin integrity and ciliated-cell formation.

   Evidence Morpholino knockdown in Xenopus with histology, EM, and RNA-seq

   PMID:26546114

   Open questions at the time

   • Direct RNA substrates underlying the skin phenotype not identified
   • Single model organism, no mammalian skin validation
4. 2018 High

   The disease relevance of EXOSC9 was unknown; biallelic variants were shown to destabilize the protein, disrupt assembly of the entire exosome, and cause neurodevelopmental defects, establishing EXOSC9 as a cause of pontocerebellar hypoplasia with spinal motor neuronopathy.

   Evidence Blue-native PAGE, patient cell western blot, zebrafish morpholino and CRISPR knockdown, RNA-seq

   PMID:29727687

   Open questions at the time

   • RNA substrates whose mis-processing drives motor neuron loss not defined
   • Why motor neurons and cerebellum are selectively vulnerable unexplained
5. 2020 Medium

   It was unclear whether EXOSC9 has cytoplasmic RNA-granule functions; depletion studies linked it to P-body formation, stress resistance, and tumor growth via its RNA-binding motif.

   Evidence siRNA knockdown, P-body quantification, RNA-seq, RNA-binding-motif mutant rescue, and xenograft assays

   PMID:32518284

   Open questions at the time

   • Mechanism linking exosome activity to P-body assembly not resolved
   • Single lab; pro-tumorigenic mechanism not generalized across cancer types
6. 2023 Medium

   How the exosome is targeted to telomeres was unknown; EXOSC9 was shown to be recruited by SUMO-HP1α to degrade TERRA and protect telomeric integrity in a cell-cycle-dependent manner.

   Evidence Co-IP, telomeric ChIP, knockdown with R-loop and DNA-damage readouts, cell-cycle analysis in breast cancer cells

   PMID:37887339

   Open questions at the time

   • Reciprocal validation of the SUMO-HP1α/EXOSC9 interaction limited
   • Generality beyond endocrine therapy-resistant breast cancer untested

• The specific RNA substrates whose processing or degradation by EXOSC9 underlies each tissue-specific phenotype (motor neuron, skin, telomere, P-body) remain unidentified, leaving the mechanistic link between exosome activity and these outcomes open.
• No direct substrate catalog tied to disease or developmental phenotypes
• No structural model of the human exosome containing EXOSC9